Gaudium IVF & Women Health IPO | The public issue is a combination of fresh issue of 1.13 crore shares worth Rs 90 crore, and an offer-for-sale of 94.93 lakh shares amounting to Rs 75 crore.

Gaudium IVF & Women’s Health sets Rs 75-79/share band for Rs 165 crore IPO

Gaudium IVF & Women Health Fixes IPO Price Band at Rs 75-79 Per Share

Gaudium IVF & Women Health, a New Delhi-based fertility services provider, has set a fixed price band of Rs 75-79 per share for its upcoming Rs 165-crore initial public offering (IPO). The company is valued at Rs 575 crore at the upper price band.

Key Highlights of Gaudium IVF & Women Health IPO

Price Band: Rs 75-79 per share
Issue Size: Rs 165 crore
Valuation: Rs 575 crore at upper price band

Offer Details

The IPO comprises a fresh issue of 1.13 crore shares worth Rs 90 crore, and an offer-for-sale of 94.93 lakh shares amounting to Rs 75 crore. Dr Manika Khanna, who holds 99.32 percent shareholding in the company, is the selling shareholder in the offer-for-sale.

Offer-for-Sale: 94.93 lakh shares worth Rs 75 crore
Fresh Issue: 1.13 crore shares worth Rs 90 crore
Selling Shareholder: Dr Manika Khanna (99.32 percent stake)

IPO Timeline

The initial public offering (IPO) will open for subscription on February 20, and close on February 24, while the one-day IPO anchor book will be launched on February 18. The IPO share allotment will be finalised by February 25, and its shares will be available for trading on the bourses effective February 27.

IPO Opening Date: February 20
IPO Closing Date: February 24
IPO Share Allotment: February 25
Listing Date: February 27

Investment Details

Investors can bid for a minimum of 189 equity shares, and in multiples of 189 shares thereafter. As a result, the minimum investment by retail investors in the offer would be Rs 14,931, and the maximum at Rs 1,94,103.

Minimum Bid Quantity: 189 equity shares
Minimum Investment: Rs 14,931
Maximum Investment: Rs 1,94,103

About Gaudium IVF & Women Health

Gaudium IVF & Women Health offers IVF (In Vitro fertilization) treatment in India and operates its business through a hub-and-spoke model. The company plans to spend Rs 50 crore of fresh issue proceeds for the establishment of new IVF centers, Rs 20 crore for repaying debt, and the remainder funds for general corporate purposes.

New IVF Centers: 19 new centers across India, with 10 in FY27, 8 in FY28, and 1 in FY29
Current Operations: More than 30 locations, comprising 7 hubs and 28 spokes

Strategic Alliance

The company has entered into a strategic alliance with Spokes i.e Infertility Expert to achieve the mutual goal of spreading awareness about ART and IVF treatment.